Nxera Pharma Co (Nxera Pharma Co) Days Inventory : 177.15 (As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is Nxera Pharma Co Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). Nxera Pharma Co's Average Total Inventories for the three months ended in Dec. 2023 was $23.60 Mil. Nxera Pharma Co's Cost of Goods Sold for the three months ended in Dec. 2023 was $12.15 Mil. Hence, Nxera Pharma Co's Days Inventory for the three months ended in Dec. 2023 was 177.15.

The historical rank and industry rank for Nxera Pharma Co's Days Inventory or its related term are showing as below:

SOLTF' s Days Inventory Range Over the Past 10 Years
Min: 12.61 Med: 92.64 Max: 271.85
Current: 271.85

During the past 13 years, Nxera Pharma Co's highest Days Inventory was 271.85. The lowest was 12.61. And the median was 92.64.

SOLTF's Days Inventory is ranked worse than
63.64% of 649 companies
in the Biotechnology industry
Industry Median: 191.36 vs SOLTF: 271.85

Nxera Pharma Co's Days Inventory increased from Dec. 2022 (15.68) to Dec. 2023 (177.15). It might indicate that Nxera Pharma Co's sales slowed down.

Warning Sign:

If a company builds up inventory, it may mean it is having difficulties selling its goods.

Inventory Turnover measures how fast the company turns over its inventory within a year. Nxera Pharma Co's Inventory Turnover for the three months ended in Dec. 2023 was 0.52.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Nxera Pharma Co's Inventory-to-Revenue for the three months ended in Dec. 2023 was 0.47.

Nxera Pharma Co Days Inventory Historical Data

The historical data trend for Nxera Pharma Co's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nxera Pharma Co Days Inventory Chart

Nxera Pharma Co Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Inventory

Get a 7-Day Free Trial

12.60

172.80

Nxera Pharma Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Inventory	Get a 7-Day Free Trial															15.68	31.43	-	323.53	177.15

Competitive Comparison of Nxera Pharma Co's Days Inventory

For the Biotechnology subindustry, Nxera Pharma Co's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nxera Pharma Co's Days Inventory Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nxera Pharma Co's Days Inventory distribution charts can be found below:

* The bar in red indicates where Nxera Pharma Co's Days Inventory falls into.

Nxera Pharma Co Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Nxera Pharma Co's Days Inventory for the fiscal year that ended in Dec. 2023 is calculated as

	Days Inventory (A: Dec. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (A: Dec. 2022 )	+	Total Inventories (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (0.237	+	20.162)	/	2 )	/	21.544	*	365
=	10.1995					/	21.544	*	365
=	172.80

Nxera Pharma Co's Days Inventory for the quarter that ended in Dec. 2023 is calculated as:

	Days Inventory (Q: Dec. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (Q: Sep. 2023 )	+	Total Inventories (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (27.028	+	20.162)	/	2 )	/	12.154	*	365 / 4
=	23.595					/	12.154	*	365 / 4
=	177.15

Nxera Pharma Co (OTCPK:SOLTF) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Nxera Pharma Co's Inventory Turnover for the three months ended in Dec. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	12.154	/	23.595
	=	0.52

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Nxera Pharma Co's Inventory to Revenue for the three months ended in Dec. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	23.595	/	50.645
	=	0.47

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

Nxera Pharma Co Days Inventory Related Terms

Thank you for viewing the detailed overview of Nxera Pharma Co's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Nxera Pharma Co (Nxera Pharma Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nxera Pharma Co Ltd (OTCPK:SOLTF) » Definitions » Days Inventory

Comparable Companies

Traded in Other Exchanges

4565:Japan JSS:Germany

Address

2-1 Kojimachi, Chiyoda-ku, PMO Hanzomon 11th Floor, Tokyo, JPN, 102-0083

Website

http://www.sosei.com

Sosei Group Corp is an international biopharmaceutical company that develops treatments for a wide range of illnesses. The company utilizes its peptide platform technologies and nanotechnology to develop its product pipeline. Sosei actively seeks partnerships to aid its product development. The company's strategy for commercializing its therapies include utilizing its subsidiaries' drug discovery technologies, supplying technology to other companies, developing products in-house, and product licensing.